Corteva, Inc. $CTVA Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB reduced its stake in Corteva, Inc. (NYSE:CTVA) by 13.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 347,071 shares of the company’s stock after selling 53,264 shares during the period. Handelsbanken Fonder AB owned approximately 0.05% of Corteva worth $29,393,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. JPL Wealth Management LLC acquired a new stake in shares of Corteva during the third quarter valued at about $25,000. Garton & Associates Financial Advisors LLC acquired a new position in shares of Corteva in the 4th quarter worth approximately $27,000. Bank of Jackson Hole Trust acquired a new position in shares of Corteva in the 4th quarter worth approximately $28,000. Cornerstone Financial Management LLC purchased a new position in shares of Corteva during the 4th quarter worth approximately $29,000. Finally, Elevation Wealth Partners LLC increased its holdings in Corteva by 334.6% in the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after purchasing an additional 261 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of Corteva stock opened at $76.34 on Wednesday. The business has a 50-day simple moving average of $81.88 and a 200-day simple moving average of $79.98. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97. The company has a market cap of $50.93 billion, a PE ratio of 50.55, a P/E/G ratio of 2.35 and a beta of 0.57.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter last year, the company earned $2.20 earnings per share. The firm’s revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on CTVA shares. Bank of America boosted their target price on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research report on Monday, July 20th. Mizuho raised their price target on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 14th. BNP Paribas Exane boosted their price objective on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Morgan Stanley increased their target price on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. Finally, Jefferies Financial Group raised their target price on Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $91.70.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.